/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./TORONTO, June 16, 2026 /CNW/ - Sun Life Financial Inc. (TSX:SLF) (NYSE:SLF) (the "Company") announced today that it intends to issue in Canada $750 million principal amount of Series 2026-1 Subordinated Unsecured 4.21% Fixed/Floating Debentures due 2038 (the "Debentures"). The offering is expected to close on June 19, 2026. The net proceeds will be used for general corporate purposes, which may include investments in subsidiaries, repayment of indebtedness and other strategic investments.Details of the offering will be set out in a pricing supplement that the Company intends to issue pursuant to its sh
- Sun Life announces offering of Subordinated Unsecured Debentures
- Chief Financial Officer Fain Clara bought $19,986 worth of shares (1,380 units at $14.48), increasing direct ownership by 0.21% to 654,073 units (SEC Form 4)
4 - Via Transportation, Inc. (0001603015) (Issuer)
- Chief Executive Officer Ramot Daniel bought $99,805 worth of shares (6,904 units at $14.46), increasing direct ownership by 0.29% to 2,420,957 units (SEC Form 4)
4 - Via Transportation, Inc. (0001603015) (Issuer)
- U.S. Bancorp Announces Quarterly Dividends
The Board of Directors of U.S. Bancorp (NYSE:USB) has declared a regular quarterly dividend of $0.52 per common share, payable July 15, 2026, to stockholders of record at the close of business on June 30, 2026. At this quarterly dividend rate, the annual dividend is equivalent to $2.08 per common share. The Board of Directors also declared the following: A regular quarterly dividend of $1,252.441 per share (equivalent to $12.524410 per depositary share) on the Series A Non-Cumulative Perpetual Preferred Stock of U.S. Bancorp, payable July 15, 2026, to stockholders of record at the close of business on June 30, 2026. A regular quarterly dividend of $286.568 per share (equivalent to $
- Kennedy Wilson Announces Expiration and Results of Fundamental Change Offer for Any and All of Its Outstanding 5.000% Senior Notes Due 2031
Kennedy-Wilson, Inc. (the "Issuer"), a wholly-owned subsidiary of global real estate investment company Kennedy-Wilson Holdings, Inc. (the "Company" or "Kennedy Wilson"), today announced the expiration and results of its previously announced offer to purchase for cash (the "Offer") any and all of its outstanding 5.000% Senior Notes due 2031 (the "Notes"), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated May 15, 2026 (the "Offer to Purchase"). The Offer was made pursuant to the Fundamental Change Offer provisions of the indenture governing the Notes (the "Indenture") in connection with the acquisition of the Company pursuant to an Agreement and Plan of M
- Sleep Number Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - Sleep Number Corp (0000827187) (Filer)
- Orla Mining Reports Voting Results of Annual Shareholder Meeting
VANCOUVER, BC, June 16, 2026 /CNW/ - Orla Mining Ltd. (TSX:OLA) (NYSE:ORLA) ("Orla" or the "Company") is pleased to report the voting results for the election of its Board of Directors, which took place at the Company's Annual General and Special Meeting of Shareholders ("AGM") held today. All nominees, as set forth in the Company's Management Information Circular dated May 8, 2026, were elected as directors of Orla at the AGM. Detailed results of the votes are set out below: NomineeVotes For% ForVotes Against% AgainstCharles Jeannes249,433,61399.91231,8970.09Jason Simpson249,474,10599.92191,4060.08Jean Robitaille229,883,30892.
- Azitra, Inc. to Present at 2026 BIO International Convention
BRANFORD, Conn., June 16, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that Cofounder and Chief Operating Officer, Travis Whitfill Ph.D., MPH, will present at BIO International Convention, being held June 22-25, 2026, in San Diego, California. The presentation will highlight recent updates and progress in Azitra's pipeline, including the launch of an innovative protein and peptide program for the cosmetic and cosmeceutical markets leveraging proprietary filaggrin technologies.Presentation Details:Ev
- Amendment: SEC Form S-4/A filed by Dick's Sporting Goods Inc
S-4/A - DICK'S SPORTING GOODS, INC. (0001089063) (Filer)
- SEC Form 11-K filed by Hewlett Packard Enterprise Company
11-K - Hewlett Packard Enterprise Co (0001645590) (Filer)
- SEC Form 11-K filed by Marriott International
11-K - MARRIOTT INTERNATIONAL INC /MD/ (0001048286) (Filer)
- Amendment: SEC Form SCHEDULE 13D/A filed by Afya Limited
SCHEDULE 13D/A - Afya Ltd (0001771007) (Subject)
- SEC Form 424B5 filed by Macerich Company
424B5 - MACERICH CO (0000912242) (Filer)
- SEC Form 11-K filed by Marriott International
11-K - MARRIOTT INTERNATIONAL INC /MD/ (0001048286) (Filer)
- SEC Form 144 filed by AnaptysBio Inc.
144 - ANAPTYSBIO, INC (0001370053) (Subject)
- SEC Form F-3 filed by RedCloud Holdings plc
F-3 - RedCloud Holdings plc (0002027360) (Filer)